Blog

Take Your Career to the Next Level with the IASLC Academy – IASLC

iaslc.org

Nov 21, 2024, 12:36

Take Your Career to the Next Level with the IASLC Academy – IASLC

IASLC shared on LinkedIn:

“Take Your Career to the Next Level with the IASLC Academy!

Are you an early career professional in thoracic oncology – or do you know someone who is? This is your opportunity to elevate your career, gain exclusive mentorship, and connect with top leaders in the field.

Program Highlights:

– Expert Mentorship: Learn from leaders in oncology, pathology, and thoracic surgery.
– Skill Building: Enhance your grant writing, communication, and global problem-solving expertise.
– Hybrid Learning Experience: Participate in 7 virtual sessions and join us in person at WCLC 2025 in Barcelona, with potential travel support!

Need Help Applying?
Don’t miss the Academy Office Hours on Wednesday, November 27, 2024 (10:00-11:00 EST) for application tips and insights to stand out!

Tag a colleague or share this with someone who would benefit from this life-changing opportunity. Together, let’s shape the future of thoracic oncology!”

IASLC

Amy C Moore, Vice President of Global Engagement and Patient Partnerships at LUNGevity Foundation, shared this post on LinkedIn, adding:

“I have been a mentor for the International Association for the Study of Lung Cancer (IASLC) Academy for the past three years. This is a fantastic opportunity for early career professionals to continue their development to become the thoracic oncology leaders of tomorrow! I always learn so much from them each year. Don’t miss out – applications open through Nov. 30!”

More posts featuring IASLC and Amy C. Moore.

Amy C. Moore is the Vice President of Global Engagement and Patient Partnerships at LUNGevity Foundation. She previously served as the Director of Science & Research at the Addario Lung Cancer Medical Institute (ALCMI). She has published peer-reviewed papers on virology, cancer, and biomarker testing in NSCLC. Dr. Moore is also an expert on COVID-19’s impact on lung cancer and serves on several advisory boards.